Viewing Study NCT00734305


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-06-14 @ 7:43 AM
Study NCT ID: NCT00734305
Status: COMPLETED
Last Update Posted: 2016-09-01
First Post: 2008-08-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Sponsor: Merrimack Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer, solid tumors, oncology, Phase I, ErbB3, HER3 View
None (erbB-3, HER-3) View